Filing Details
- Accession Number:
- 0001144204-18-003086
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-01-22 16:22:53
- Reporting Period:
- 2018-01-17
- Accepted Time:
- 2018-01-22 16:22:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1563665 | Biostage Inc. | BSTG | Surgical & Medical Instruments & Apparatus (3841) | 455210462 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1727656 | Dst Capital Llc | C/O Biostage, Inc. 84 October Hill Road, Suite 11 Holliston MA 01746 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-01-17 | 5,000 | $2.20 | 10,450 | No | 4 | P | Indirect | Owned by sole member of reporting person |
| Common Stock | Acquisiton | 2018-01-19 | 3,700 | $2.60 | 14,150 | No | 4 | P | Indirect | Owned by sole member of reporting person |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | Owned by sole member of reporting person |
| No | 4 | P | Indirect | Owned by sole member of reporting person |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 500,000 | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.152 to $2.20, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.5999 to $2.60, inclusive. The reporting person hereby undertakes to provide to Biostage, Inc., any security holder of Biostage, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
Billionaire Hedge Funds
